Summary Ocata Therapeutics, Inc. (Ocata) formerly known as Advanced Cell Technology, Inc. is a clinical stage biotechnology company that specializes in regenerative medicine. The company develops and commercializes for various ophthalmological disorders including Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. It key development programs include RPE Cell Therapy; Photoreceptor Progenitor Cell Therapy; Ganglion Progenitor Cell Therapy and Corneal Endothelial Cells. The company also has projects in preclinical development for various indications including autoimmune, inflammatory and wound healing-related disorders. It operates a laboratory and manufacturing facility in Marlborough, in the US. Ocata is headquartered in Marlborough, Massachusetts, the US. Ocata Therapeutics, Inc. (OCAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their... Research Beam Model: Research Beam Product ID: 452274 250 USD New
Ocata Therapeutics, Inc. (OCAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Ocata Therapeutics, Inc. (OCAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : March   2016
  • Pages : 32
  • Publisher : GlobalData
 
 
 
Summary

Ocata Therapeutics, Inc. (Ocata) formerly known as Advanced Cell Technology, Inc. is a clinical stage biotechnology company that specializes in regenerative medicine. The company develops and commercializes for various ophthalmological disorders including Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. It key development programs include RPE Cell Therapy; Photoreceptor Progenitor Cell Therapy; Ganglion Progenitor Cell Therapy and Corneal Endothelial Cells. The company also has projects in preclinical development for various indications including autoimmune, inflammatory and wound healing-related disorders. It operates a laboratory and manufacturing facility in Marlborough, in the US. Ocata is headquartered in Marlborough, Massachusetts, the US.

Ocata Therapeutics, Inc. (OCAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Ocata Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Ocata Therapeutics Secures USD6 Million from Silicon Valley Bank 11
Partnerships 12
Advanced Cell Enters Into Co-Marketing Agreement With Roslin Cells 12
Licensing Agreements 14
Ocata Therapeutics Enters into Licensing Agreement with Allele Biotech 14
International Stem Cell Amends Licensing Agreement With Advanced Cell Technology 15
SCRMI Enters Into Licensing Agreement With Advanced Cell And CHA Bio 16
Equity Offering 18
Ocata Therapeutics Prices Public Offering of Shares and Warrants for USD30 Million 18
Advanced Cell to Raise USD30 Million in Private Placement of Shares 20
Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For US$35 Million 21
Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For US$1 Million 22
Advanced Cell Technology Completes Private Placement Of US$4 Million 23
Advanced Cell Technology Completes First Tranche Private Placement Of US$1.5 Million 25
Acquisition 27
Astellas Pharma Acquires Ocata Therapeutics for up to USD384 Million in Tender Offer 27
Ocata Therapeutics, Inc. - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List Of Tables
List of Tables
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ocata Therapeutics, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Ocata Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Ocata Therapeutics Secures USD6 Million from Silicon Valley Bank 11
Advanced Cell Enters Into Co-Marketing Agreement With Roslin Cells 12
Ocata Therapeutics Enters into Licensing Agreement with Allele Biotech 14
International Stem Cell Amends Licensing Agreement With Advanced Cell Technology 15
SCRMI Enters Into Licensing Agreement With Advanced Cell And CHA Bio 16
Ocata Therapeutics Prices Public Offering of Shares and Warrants for USD30 Million 18
Advanced Cell to Raise USD30 Million in Private Placement of Shares 20
Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For US$35 Million 21
Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For US$1 Million 22
Advanced Cell Technology Completes Private Placement Of US$4 Million 23
Advanced Cell Technology Completes First Tranche Private Placement Of US$1.5 Million 25
Astellas Pharma Acquires Ocata Therapeutics for up to USD384 Million in Tender Offer 27
Ocata Therapeutics, Inc., Key Competitors 29
Ocata Therapeutics, Inc., Key Employees 30
Ocata Therapeutics, Inc., Other Locations 31
Ocata Therapeutics, Inc., Subsidiaries 31
List Of Figures
List of Figures
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ocata Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Ocata Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter